Get started Log in

CRMD — CorMedix Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Market Cap
$631.35m
Enterprise Value
$519.81m
Revenue
$311.71m

Brief: CorMedix Files For Mixed Shelf Of Up To $150 Mln
09/05/2024 22:08
CorMedix Inc reports results for the quarter ended in March - Earnings Summary
09/05/2024 21:19
CorMedix Inc expected to post a loss of 28 cents a share - Earnings Preview
07/05/2024 18:26
Brief: CorMedix Announces US Inpatient Commercial Availability Of DefenCath
15/04/2024 13:38
Brief: CorMedix Announces Commercial Agreement With ARC Dialysis
08/04/2024 13:38
CorMedix Inc reports results for the quarter ended in December - Earnings Summary
12/03/2024 13:31
Brief: CorMedix Q4 EPS USD -0.26
12/03/2024 11:38
CorMedix Inc expected to post a loss of 20 cents a share - Earnings Preview
08/03/2024 13:04
Brief: CorMedix Believes It Has Sufficient Cash, Cash Equivalents And Available Resources To Fund Commercial Launch Of DefenCath
08/01/2024 17:45
Brief: CorMedix Announces Partnership With The Leapfrog Group
04/12/2023 15:10
U.S. RESEARCH ROUNDUP-Biomarin Pharmaceutical, Cisco, Microsoft
16/11/2023 07:10
CorMedix rises on US FDA approval for antimicrobial drug, smaller Q3 loss
15/11/2023 15:33
US FDA approves CorMedix's antimicrobial drug (updated)
15/11/2023 15:23
U.S. FDA approves CorMedix's antimicrobial drug
15/11/2023 15:08
U.S. RESEARCH ROUNDUP-Beauty Health, Design Therapeutics, Energizer Holdings
15/11/2023 07:25
What to Watch in the Day Ahead - Wednesday, November 15
14/11/2023 19:30
Brief: CorMedix Pursues FDA Approval Of Defencath
08/09/2023 14:48
Brief: Cormedix Announces Issuance Of U.S. Patent Covering Lead Product Defencath
30/08/2023 13:09
Brief: Cormedix's Board Will Be Reduced To Seven Directors Effective As Of Oct 15, 2023
17/08/2023 13:32
U.S. RESEARCH ROUNDUP-Celanese, Draftkings, Sovos Brands
09/08/2023 08:38